Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
The NINCDS–ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the
prevailing diagnostic standards in research; however, they have now fallen behind the …
prevailing diagnostic standards in research; however, they have now fallen behind the …
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
B Vellas, N Coley, PJ Ousset, G Berrut… - The Lancet …, 2012 - thelancet.com
Background Prevention strategies are urgently needed to tackle the growing burden of
Alzheimer's disease. We aimed to assess efficacy of long-term use of standardised ginkgo …
Alzheimer's disease. We aimed to assess efficacy of long-term use of standardised ginkgo …
Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease?
P Celsis - Annals of medicine, 2000 - Taylor & Francis
With the promising development of effective treatment, significant improvement in the very
early diagnosis of Alzheimer's disease (AD) is required. There is vast agreement that a …
early diagnosis of Alzheimer's disease (AD) is required. There is vast agreement that a …
Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study
H Amieva, C Meillon, C Helmer, P Barberger-Gateau… - PLoS …, 2013 - journals.plos.org
Background Numerous studies have looked at the potential benefits of various nootropic
drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on …
drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on …
[HTML][HTML] The primary care physician and Alzheimer's disease: an international position paper
This paper aims to define the role of the primary care physician (PCP) in the management of
Alzheimer's disease (AD) and to propose a model for a work plan. The proposals in this …
Alzheimer's disease (AD) and to propose a model for a work plan. The proposals in this …
Executive functions in clinical and preclinical Alzheimer's disease
P Allain, F Etcharry-Bouyx, C Verny - Revue neurologique, 2013 - Elsevier
Executive functions is an umbrella term describing a wide range of higher order processes
that allow the flexible modification of thought and behaviour in response to changing …
that allow the flexible modification of thought and behaviour in response to changing …
Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment
MO Habert, JF Horn, M Sarazin, JA Lotterie, M Puel… - Neurobiology of …, 2011 - Elsevier
OBJECTIVE: To improve diagnosis of early Alzheimer's disease (AD), ie, prodromal AD, by
an automated quantitative tool combining brain perfusion single-photon emission computed …
an automated quantitative tool combining brain perfusion single-photon emission computed …
Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis
We investigated the earliest neuropsychological changes in Alzheimer's disease (AD) by
comparing the baseline performance of 29 individuals who subsequently developed AD …
comparing the baseline performance of 29 individuals who subsequently developed AD …
GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale …
S Andrieu, PJ Ousset, N Coley, M Ouzid… - Current Alzheimer …, 2008 - ingentaconnect.com
Primary and secondary prevention strategies for Alzheimer's disease (AD) are urgently
needed. We have initiated a five-year prospective prevention study involving patients …
needed. We have initiated a five-year prospective prevention study involving patients …
The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761® for prevention of Alzheimer disease in patients over 70 …
Background: Preventive approaches in the field of Alzheimer disease (AD) is important but
these trials raise many questions. Which protective factor should be studied? What …
these trials raise many questions. Which protective factor should be studied? What …